nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—BCHE—Alzheimer's disease	0.388	1	CbGaD
Triflupromazine—BCHE—Rivastigmine—Alzheimer's disease	0.26	0.507	CbGbCtD
Triflupromazine—BCHE—Galantamine—Alzheimer's disease	0.134	0.261	CbGbCtD
Triflupromazine—DRD2—Memantine—Alzheimer's disease	0.119	0.233	CbGbCtD
Triflupromazine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00616	0.164	CbGeAlD
Triflupromazine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00364	0.0968	CbGeAlD
Triflupromazine—DRD1—forebrain—Alzheimer's disease	0.00161	0.0428	CbGeAlD
Triflupromazine—DRD1—telencephalon—Alzheimer's disease	0.00148	0.0393	CbGeAlD
Triflupromazine—CHRM2—forebrain—Alzheimer's disease	0.0013	0.0345	CbGeAlD
Triflupromazine—CHRM2—telencephalon—Alzheimer's disease	0.00119	0.0317	CbGeAlD
Triflupromazine—CHRM1—forebrain—Alzheimer's disease	0.00118	0.0314	CbGeAlD
Triflupromazine—HTR2B—forebrain—Alzheimer's disease	0.00117	0.0312	CbGeAlD
Triflupromazine—CHRM1—telencephalon—Alzheimer's disease	0.00109	0.0288	CbGeAlD
Triflupromazine—HTR2B—telencephalon—Alzheimer's disease	0.00108	0.0287	CbGeAlD
Triflupromazine—DRD2—forebrain—Alzheimer's disease	0.000951	0.0253	CbGeAlD
Triflupromazine—DRD2—telencephalon—Alzheimer's disease	0.000874	0.0232	CbGeAlD
Triflupromazine—DRD1—nervous system—Alzheimer's disease	0.000873	0.0232	CbGeAlD
Triflupromazine—BCHE—forebrain—Alzheimer's disease	0.000862	0.0229	CbGeAlD
Triflupromazine—DRD1—central nervous system—Alzheimer's disease	0.000841	0.0224	CbGeAlD
Triflupromazine—BCHE—telencephalon—Alzheimer's disease	0.000793	0.0211	CbGeAlD
Triflupromazine—ABCB1—blood vessel—Alzheimer's disease	0.000779	0.0207	CbGeAlD
Triflupromazine—CHRM2—nervous system—Alzheimer's disease	0.000704	0.0187	CbGeAlD
Triflupromazine—CHRM2—central nervous system—Alzheimer's disease	0.000678	0.018	CbGeAlD
Triflupromazine—DRD1—brain—Alzheimer's disease	0.000668	0.0177	CbGeAlD
Triflupromazine—CHRM1—nervous system—Alzheimer's disease	0.000641	0.017	CbGeAlD
Triflupromazine—HTR2B—nervous system—Alzheimer's disease	0.000637	0.0169	CbGeAlD
Triflupromazine—CHRM1—central nervous system—Alzheimer's disease	0.000617	0.0164	CbGeAlD
Triflupromazine—HTR2B—central nervous system—Alzheimer's disease	0.000614	0.0163	CbGeAlD
Triflupromazine—CHRM2—brain—Alzheimer's disease	0.000538	0.0143	CbGeAlD
Triflupromazine—DRD2—nervous system—Alzheimer's disease	0.000516	0.0137	CbGeAlD
Triflupromazine—DRD2—central nervous system—Alzheimer's disease	0.000497	0.0132	CbGeAlD
Triflupromazine—CHRM1—brain—Alzheimer's disease	0.00049	0.013	CbGeAlD
Triflupromazine—HTR2B—brain—Alzheimer's disease	0.000487	0.0129	CbGeAlD
Triflupromazine—DRD2—cerebellum—Alzheimer's disease	0.000486	0.0129	CbGeAlD
Triflupromazine—Dimetacrine—ACHE—Alzheimer's disease	0.000473	0.0866	CrCbGaD
Triflupromazine—BCHE—nervous system—Alzheimer's disease	0.000468	0.0124	CbGeAlD
Triflupromazine—ABCB1—embryo—Alzheimer's disease	0.000465	0.0123	CbGeAlD
Triflupromazine—BCHE—central nervous system—Alzheimer's disease	0.000451	0.012	CbGeAlD
Triflupromazine—BCHE—cerebellum—Alzheimer's disease	0.00044	0.0117	CbGeAlD
Triflupromazine—ABCB1—forebrain—Alzheimer's disease	0.000411	0.0109	CbGeAlD
Triflupromazine—DRD2—brain—Alzheimer's disease	0.000394	0.0105	CbGeAlD
Triflupromazine—ABCB1—telencephalon—Alzheimer's disease	0.000378	0.01	CbGeAlD
Triflupromazine—BCHE—brain—Alzheimer's disease	0.000358	0.00951	CbGeAlD
Triflupromazine—Mesoridazine—HTR6—Alzheimer's disease	0.000242	0.0444	CrCbGaD
Triflupromazine—Fluphenazine—CALM1—Alzheimer's disease	0.000235	0.0431	CrCbGaD
Triflupromazine—ABCB1—nervous system—Alzheimer's disease	0.000223	0.00593	CbGeAlD
Triflupromazine—ABCB1—central nervous system—Alzheimer's disease	0.000215	0.00571	CbGeAlD
Triflupromazine—Fluphenazine—HTR6—Alzheimer's disease	0.000212	0.0389	CrCbGaD
Triflupromazine—ABCB1—cerebellum—Alzheimer's disease	0.00021	0.00558	CbGeAlD
Triflupromazine—Clomipramine—HTR6—Alzheimer's disease	0.000194	0.0356	CrCbGaD
Triflupromazine—Chlorprothixene—HTR6—Alzheimer's disease	0.000193	0.0354	CrCbGaD
Triflupromazine—Promethazine—CALM1—Alzheimer's disease	0.000191	0.0349	CrCbGaD
Triflupromazine—Trifluoperazine—CALM1—Alzheimer's disease	0.000188	0.0345	CrCbGaD
Triflupromazine—Perphenazine—CALM1—Alzheimer's disease	0.000186	0.0341	CrCbGaD
Triflupromazine—Thioridazine—HTR6—Alzheimer's disease	0.000183	0.0335	CrCbGaD
Triflupromazine—ABCB1—brain—Alzheimer's disease	0.00017	0.00453	CbGeAlD
Triflupromazine—Trifluoperazine—HTR6—Alzheimer's disease	0.00017	0.0311	CrCbGaD
Triflupromazine—Perphenazine—HTR6—Alzheimer's disease	0.000168	0.0307	CrCbGaD
Triflupromazine—Ethopropazine—BCHE—Alzheimer's disease	0.000165	0.0303	CrCbGaD
Triflupromazine—Chlorpromazine—CALM1—Alzheimer's disease	0.000148	0.027	CrCbGaD
Triflupromazine—Cinacalcet—CYP2D6—Alzheimer's disease	0.000142	0.0261	CrCbGaD
Triflupromazine—Chlorpromazine—HTR6—Alzheimer's disease	0.000133	0.0244	CrCbGaD
Triflupromazine—Imipramine—HTR6—Alzheimer's disease	0.000132	0.0243	CrCbGaD
Triflupromazine—Cyamemazine—HTR2A—Alzheimer's disease	0.000117	0.0214	CrCbGaD
Triflupromazine—Mequitazine—CYP2D6—Alzheimer's disease	9.29e-05	0.017	CrCbGaD
Triflupromazine—Diltiazem—CYP2D6—Alzheimer's disease	8.33e-05	0.0153	CrCbGaD
Triflupromazine—Acepromazine—HTR2A—Alzheimer's disease	7.51e-05	0.0138	CrCbGaD
Triflupromazine—Clomipramine—SLC6A4—Alzheimer's disease	7.43e-05	0.0136	CrCbGaD
Triflupromazine—Thioproperazine—HTR2A—Alzheimer's disease	7.34e-05	0.0135	CrCbGaD
Triflupromazine—Pipotiazine—HTR2A—Alzheimer's disease	7.22e-05	0.0132	CrCbGaD
Triflupromazine—Mesoridazine—HTR2A—Alzheimer's disease	7.13e-05	0.0131	CrCbGaD
Triflupromazine—Pipotiazine—CYP2D6—Alzheimer's disease	6.61e-05	0.0121	CrCbGaD
Triflupromazine—Chlorpromazine—BCHE—Alzheimer's disease	6.53e-05	0.012	CrCbGaD
Triflupromazine—Mesoridazine—CYP2D6—Alzheimer's disease	6.52e-05	0.0119	CrCbGaD
Triflupromazine—Prochlorperazine—CYP2D6—Alzheimer's disease	6.31e-05	0.0116	CrCbGaD
Triflupromazine—Fluphenazine—HTR2A—Alzheimer's disease	6.24e-05	0.0114	CrCbGaD
Triflupromazine—Propiomazine—HTR2A—Alzheimer's disease	6.01e-05	0.011	CrCbGaD
Triflupromazine—Desipramine—SLC6A4—Alzheimer's disease	5.98e-05	0.011	CrCbGaD
Triflupromazine—Clomipramine—HTR2A—Alzheimer's disease	5.71e-05	0.0105	CrCbGaD
Triflupromazine—Fluphenazine—CYP2D6—Alzheimer's disease	5.71e-05	0.0105	CrCbGaD
Triflupromazine—Chlorprothixene—HTR2A—Alzheimer's disease	5.69e-05	0.0104	CrCbGaD
Triflupromazine—Thioridazine—HTR2A—Alzheimer's disease	5.38e-05	0.00986	CrCbGaD
Triflupromazine—Clomipramine—CYP2D6—Alzheimer's disease	5.22e-05	0.00957	CrCbGaD
Triflupromazine—Methotrimeprazine—HTR2A—Alzheimer's disease	5.14e-05	0.00941	CrCbGaD
Triflupromazine—Imipramine—SLC6A4—Alzheimer's disease	5.07e-05	0.00929	CrCbGaD
Triflupromazine—Promethazine—HTR2A—Alzheimer's disease	5.06e-05	0.00927	CrCbGaD
Triflupromazine—Trifluoperazine—HTR2A—Alzheimer's disease	4.99e-05	0.00915	CrCbGaD
Triflupromazine—Perphenazine—HTR2A—Alzheimer's disease	4.94e-05	0.00905	CrCbGaD
Triflupromazine—Thioridazine—CYP2D6—Alzheimer's disease	4.92e-05	0.00901	CrCbGaD
Triflupromazine—Methotrimeprazine—CYP2D6—Alzheimer's disease	4.7e-05	0.00861	CrCbGaD
Triflupromazine—Promethazine—CYP2D6—Alzheimer's disease	4.63e-05	0.00848	CrCbGaD
Triflupromazine—Desipramine—HTR2A—Alzheimer's disease	4.59e-05	0.00842	CrCbGaD
Triflupromazine—Perphenazine—CYP2D6—Alzheimer's disease	4.52e-05	0.00827	CrCbGaD
Triflupromazine—Promazine—HTR2A—Alzheimer's disease	4.45e-05	0.00815	CrCbGaD
Triflupromazine—Desipramine—CYP2D6—Alzheimer's disease	4.2e-05	0.0077	CrCbGaD
Triflupromazine—Chlorpromazine—HTR2A—Alzheimer's disease	3.92e-05	0.00718	CrCbGaD
Triflupromazine—Imipramine—HTR2A—Alzheimer's disease	3.9e-05	0.00714	CrCbGaD
Triflupromazine—Chlorpromazine—CYP2D6—Alzheimer's disease	3.58e-05	0.00656	CrCbGaD
Triflupromazine—Imipramine—CYP2D6—Alzheimer's disease	3.56e-05	0.00653	CrCbGaD
Triflupromazine—CHRM2—Signaling Pathways—CRH—Alzheimer's disease	1.24e-05	0.000224	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.24e-05	0.000223	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.24e-05	0.000223	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCR5—Alzheimer's disease	1.24e-05	0.000223	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.24e-05	0.000223	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—LPL—Alzheimer's disease	1.23e-05	0.000222	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF2—Alzheimer's disease	1.23e-05	0.000222	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCR5—Alzheimer's disease	1.23e-05	0.000221	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—S100B—Alzheimer's disease	1.22e-05	0.00022	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NPS—Alzheimer's disease	1.22e-05	0.000219	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	1.22e-05	0.000219	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.21e-05	0.000218	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—HTR2A—Alzheimer's disease	1.2e-05	0.000216	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—F2—Alzheimer's disease	1.2e-05	0.000216	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTK2B—Alzheimer's disease	1.2e-05	0.000215	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NPS—Alzheimer's disease	1.19e-05	0.000215	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1R—Alzheimer's disease	1.19e-05	0.000214	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.19e-05	0.000214	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.19e-05	0.000214	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NPS—Alzheimer's disease	1.18e-05	0.000212	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—F2—Alzheimer's disease	1.17e-05	0.000211	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PPP3CA—Alzheimer's disease	1.17e-05	0.000211	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTK2B—Alzheimer's disease	1.17e-05	0.000211	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SST—Alzheimer's disease	1.16e-05	0.000209	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NTRK2—Alzheimer's disease	1.16e-05	0.000209	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GAB2—Alzheimer's disease	1.16e-05	0.000209	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF2—Alzheimer's disease	1.16e-05	0.000209	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CALM1—Alzheimer's disease	1.16e-05	0.000208	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—F2—Alzheimer's disease	1.16e-05	0.000208	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTK2B—Alzheimer's disease	1.16e-05	0.000208	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GSK3A—Alzheimer's disease	1.15e-05	0.000207	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.15e-05	0.000206	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—LPL—Alzheimer's disease	1.14e-05	0.000206	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GAB2—Alzheimer's disease	1.14e-05	0.000205	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SST—Alzheimer's disease	1.14e-05	0.000205	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NTRK2—Alzheimer's disease	1.14e-05	0.000205	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CALM1—Alzheimer's disease	1.13e-05	0.000204	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APP—Alzheimer's disease	1.13e-05	0.000204	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MEF2C—Alzheimer's disease	1.13e-05	0.000204	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GSK3A—Alzheimer's disease	1.13e-05	0.000203	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1R—Alzheimer's disease	1.12e-05	0.000202	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GAB2—Alzheimer's disease	1.12e-05	0.000202	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NTRK2—Alzheimer's disease	1.12e-05	0.000202	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SST—Alzheimer's disease	1.12e-05	0.000202	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CALM1—Alzheimer's disease	1.12e-05	0.000201	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GSK3A—Alzheimer's disease	1.11e-05	0.0002	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—MTHFR—Alzheimer's disease	1.11e-05	0.0002	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PRKCG—Alzheimer's disease	1.11e-05	0.0002	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APP—Alzheimer's disease	1.11e-05	0.0002	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—A2M—Alzheimer's disease	1.11e-05	0.000199	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.11e-05	0.000199	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APP—Alzheimer's disease	1.1e-05	0.000197	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—F2—Alzheimer's disease	1.09e-05	0.000196	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NGF—Alzheimer's disease	1.08e-05	0.000195	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LPL—Alzheimer's disease	1.08e-05	0.000194	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	1.07e-05	0.000192	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MEF2C—Alzheimer's disease	1.07e-05	0.000192	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—F2—Alzheimer's disease	1.07e-05	0.000192	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR5—Alzheimer's disease	1.05e-05	0.000189	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—F2—Alzheimer's disease	1.05e-05	0.000189	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PRKCG—Alzheimer's disease	1.05e-05	0.000188	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PLCB1—Alzheimer's disease	1.05e-05	0.000188	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CALM1—Alzheimer's disease	1.04e-05	0.000187	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—APOE—Alzheimer's disease	1.04e-05	0.000186	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PLCB1—Alzheimer's disease	1.03e-05	0.000186	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—HTR2A—Alzheimer's disease	1.03e-05	0.000185	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—CAV1—Alzheimer's disease	1.03e-05	0.000184	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NGF—Alzheimer's disease	1.02e-05	0.000184	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	9.98e-06	0.00018	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR5—Alzheimer's disease	9.93e-06	0.000179	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	9.92e-06	0.000178	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NGFR—Alzheimer's disease	9.77e-06	0.000176	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	9.75e-06	0.000175	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—HTR2A—Alzheimer's disease	9.72e-06	0.000175	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CREB1—Alzheimer's disease	9.71e-06	0.000175	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	9.71e-06	0.000175	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NGFR—Alzheimer's disease	9.64e-06	0.000173	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ACHE—Alzheimer's disease	9.64e-06	0.000173	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CALM1—Alzheimer's disease	9.61e-06	0.000173	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CREB1—Alzheimer's disease	9.58e-06	0.000172	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—LEP—Alzheimer's disease	9.58e-06	0.000172	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—APOE—Alzheimer's disease	9.58e-06	0.000172	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ADAM10—Alzheimer's disease	9.54e-06	0.000172	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	9.52e-06	0.000171	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL2—Alzheimer's disease	9.5e-06	0.000171	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CAV1—Alzheimer's disease	9.49e-06	0.000171	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ADAM10—Alzheimer's disease	9.42e-06	0.000169	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL2—Alzheimer's disease	9.38e-06	0.000169	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	9.35e-06	0.000168	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—S100B—Alzheimer's disease	9.22e-06	0.000166	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ESR1—Alzheimer's disease	9.15e-06	0.000164	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CALM1—Alzheimer's disease	9.07e-06	0.000163	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—F2—Alzheimer's disease	9.04e-06	0.000162	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—LEP—Alzheimer's disease	9.04e-06	0.000162	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APOE—Alzheimer's disease	9.04e-06	0.000162	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ENO1—Alzheimer's disease	9.03e-06	0.000162	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	9.03e-06	0.000162	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—S100B—Alzheimer's disease	9.02e-06	0.000162	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PPARG—Alzheimer's disease	9.02e-06	0.000162	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CAV1—Alzheimer's disease	8.95e-06	0.000161	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—S100B—Alzheimer's disease	8.91e-06	0.00016	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	8.86e-06	0.000159	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—INS—Alzheimer's disease	8.84e-06	0.000159	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOTCH1—Alzheimer's disease	8.84e-06	0.000159	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	8.78e-06	0.000158	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ESR1—Alzheimer's disease	8.63e-06	0.000155	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF2—Alzheimer's disease	8.59e-06	0.000155	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—F2—Alzheimer's disease	8.52e-06	0.000153	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	8.49e-06	0.000153	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF2—Alzheimer's disease	8.48e-06	0.000153	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—BCHE—Alzheimer's disease	8.39e-06	0.000151	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	8.34e-06	0.00015	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1R—Alzheimer's disease	8.31e-06	0.000149	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—GSK3B—Alzheimer's disease	8.3e-06	0.000149	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CREB1—Alzheimer's disease	8.23e-06	0.000148	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1R—Alzheimer's disease	8.2e-06	0.000147	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—INS—Alzheimer's disease	8.18e-06	0.000147	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LPL—Alzheimer's disease	8.14e-06	0.000146	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	8.07e-06	0.000145	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	8.05e-06	0.000145	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	7.96e-06	0.000143	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	7.92e-06	0.000142	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	7.92e-06	0.000142	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	7.91e-06	0.000142	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	7.89e-06	0.000142	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	7.86e-06	0.000141	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GSK3B—Alzheimer's disease	7.82e-06	0.000141	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	7.79e-06	0.00014	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CREB1—Alzheimer's disease	7.76e-06	0.00014	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—NOS3—Alzheimer's disease	7.75e-06	0.000139	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	7.74e-06	0.000139	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—INS—Alzheimer's disease	7.72e-06	0.000139	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	7.71e-06	0.000139	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	7.68e-06	0.000138	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	7.64e-06	0.000137	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL2—Alzheimer's disease	7.59e-06	0.000137	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	7.54e-06	0.000136	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	7.5e-06	0.000135	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	7.47e-06	0.000134	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	7.45e-06	0.000134	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	7.34e-06	0.000132	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	7.34e-06	0.000132	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	7.24e-06	0.00013	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	7.18e-06	0.000129	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	7.18e-06	0.000129	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—Alzheimer's disease	7.09e-06	0.000128	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	7.09e-06	0.000127	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	6.85e-06	0.000123	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	6.82e-06	0.000123	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	6.82e-06	0.000123	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	6.77e-06	0.000122	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	6.76e-06	0.000122	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	6.7e-06	0.00012	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	6.68e-06	0.00012	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	6.68e-06	0.00012	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	6.62e-06	0.000119	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	6.61e-06	0.000119	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	6.61e-06	0.000119	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	6.59e-06	0.000119	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	6.59e-06	0.000119	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	6.59e-06	0.000118	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	6.53e-06	0.000117	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	6.51e-06	0.000117	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—F2—Alzheimer's disease	6.43e-06	0.000116	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	6.37e-06	0.000115	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	6.3e-06	0.000113	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.3e-06	0.000113	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	6.29e-06	0.000113	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	6.21e-06	0.000112	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	6.16e-06	0.000111	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	6.15e-06	0.000111	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	6.09e-06	0.00011	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	6.08e-06	0.000109	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	6.05e-06	0.000109	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—LPL—Alzheimer's disease	6.02e-06	0.000108	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	5.91e-06	0.000106	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	5.86e-06	0.000105	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—INS—Alzheimer's disease	5.83e-06	0.000105	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	5.8e-06	0.000104	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	5.78e-06	0.000104	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	5.75e-06	0.000103	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	5.74e-06	0.000103	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	5.73e-06	0.000103	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	5.71e-06	0.000103	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	5.71e-06	0.000103	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	5.7e-06	0.000103	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	5.66e-06	0.000102	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	5.64e-06	0.000101	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	5.63e-06	0.000101	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	5.61e-06	0.000101	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	5.6e-06	0.000101	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	5.59e-06	0.0001	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	5.54e-06	9.96e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	5.52e-06	9.92e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	5.45e-06	9.79e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	5.42e-06	9.75e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	5.28e-06	9.5e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	5.27e-06	9.47e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	5.17e-06	9.3e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	5.11e-06	9.19e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CALM1—Alzheimer's disease	5.07e-06	9.11e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—APOE—Alzheimer's disease	5.05e-06	9.08e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAV1—Alzheimer's disease	5e-06	9e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	5e-06	8.99e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	4.94e-06	8.88e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	4.88e-06	8.77e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	4.75e-06	8.53e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	4.48e-06	8.05e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARG—Alzheimer's disease	4.4e-06	7.91e-05	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.38e-06	7.87e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	4.34e-06	7.8e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—INS—Alzheimer's disease	4.31e-06	7.76e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	4.31e-06	7.75e-05	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	4.29e-06	7.71e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	4.25e-06	7.64e-05	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	4.23e-06	7.61e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	4.22e-06	7.59e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	4.19e-06	7.54e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	4.16e-06	7.49e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	3.99e-06	7.17e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	3.98e-06	7.15e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	3.91e-06	7.03e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	3.9e-06	7.02e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	3.89e-06	7e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	3.85e-06	6.93e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	3.84e-06	6.91e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.78e-06	6.8e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	3.68e-06	6.63e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	3.68e-06	6.62e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	3.6e-06	6.48e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	3.58e-06	6.43e-05	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—Alzheimer's disease	3.56e-06	6.41e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	3.56e-06	6.4e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.46e-06	6.22e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	3.38e-06	6.08e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	3.37e-06	6.07e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	3.31e-06	5.95e-05	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	3.3e-06	5.93e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	3.26e-06	5.87e-05	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	3.11e-06	5.6e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2.78e-06	5e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2.72e-06	4.9e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	2.69e-06	4.83e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	2.55e-06	4.58e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	2.49e-06	4.48e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	2.46e-06	4.42e-05	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	2.35e-06	4.22e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	2.3e-06	4.13e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	2.27e-06	4.08e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.74e-06	3.13e-05	CbGpPWpGaD
